Layoffs?


















The feds will be revising the PFS for the TC 88300's in 2013...uhh...better be ready for big cut in reimbursement...especially the labs leveraged highly in 88305...better ratchet up the volume...only way to maintain any margin...better diversify...EMR donations going away...ACO's coming online...hospitals buying up practices...TC grandfather gone...reimbursement models changing...oh, my friend...you are delusional if you think the money will continue to freely flow...the Affordable Care act and IOAT of AP by the GI, GU and derms have sealed the deal for the point and click model of reimbursement...
 










88305 TC rumored to be getting cut 30 to 50%....like i said before..doesnt make any difference if you fear feds or not...the reimbursement ax is coming ...and it wont be a pretty cut
 


So...here is round two...CMS looking to revise IHC, special stain and cytology TC and PC for 2014 PFS....fear the feds?...again...fear is irrevalant....AP is getting economically marginalized into more of a commodity than it already is...best of luck to.us all...
 






Yep...here it is...read below

better get the whips out on the pathologists....have to sign out 2x as many CPT as before to get same reimbursement before cut...oh...wait..cost to make slide wont change...so wont matter how much you sign out...death spiral...hmmmm...better be diversified and can make a value-added claim to beg for more ohms from the feds...

wait...you mentioned the good news...what was that going to be? you have changed careers?


CMS Cuts 88305 TC by 52%, Molecular Codes Go On CLFS

November 1—Advancing its commitment to contain health care delivery costs, CMS announced a series of physician pay cuts impacting pathologists in the final 2013 Physician Fee Schedule released today. Most notably, the agency lowered the technical component (TC) of the surgical pathology code 88305 by 52%, although it raised the professional component by 2%, beginning Jan. 1. This change alters the global payment for this code, which will decrease by 33% as a result of this revaluation. The agency also announced that the newly developed molecular pathology CPT codes would be placed on the Medicare Clinical Laboratory Fee Schedule (CLFS). A new CMS HCPCS II G-code was created for situations requiring physician interpretation and reporting of these tests for Medicare beneficiariess.
 







Write your reply...